0001209191-22-016541.txt : 20220304
0001209191-22-016541.hdr.sgml : 20220304
20220304215144
ACCESSION NUMBER: 0001209191-22-016541
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220302
FILED AS OF DATE: 20220304
DATE AS OF CHANGE: 20220304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cruse Michael
CENTRAL INDEX KEY: 0001854179
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40315
FILM NUMBER: 22716085
MAIL ADDRESS:
STREET 1: C/O RENEO PHARMACEUTICALS, INC.
STREET 2: 12230 EL CAMINO REAL, SUITE 230
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Reneo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001637715
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472309515
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18575 JAMBOREE ROAD
STREET 2: SUITE 275-S
CITY: IRVINE
STATE: CA
ZIP: 92612
BUSINESS PHONE: (858) 283-0280
MAIL ADDRESS:
STREET 1: 18575 JAMBOREE ROAD
STREET 2: SUITE 275-S
CITY: IRVINE
STATE: CA
ZIP: 92612
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-02
0
0001637715
Reneo Pharmaceuticals, Inc.
RPHM
0001854179
Cruse Michael
C/O RENEO PHARMACEUTICALS, INC.
18575 JAMBOREE ROAD, SUITE 275-S
IRVINE
CA
92612
0
1
0
0
Chief Operating Officer
Stock option (right to buy)
4.58
2022-03-02
4
A
0
25000
0.00
A
2032-03-01
Common Stock
25000
25000
D
The shares vest in a series of 48 successive equal monthly installments measured from March 2, 2022, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date.
/s/ Vineet R. Jindal, Attorney-in-Fact
2022-03-04